Efficacy and safety of an extended-release niacin (niaspan): a long-term study
- 1 December 1998
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (12) , 74U-81U
- https://doi.org/10.1016/s0002-9149(98)00731-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aggressive medical therapy for the prevention and treatment of coronary artery diseaseDisease-a-Month, 1998
- Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled TrialJournal of Cardiovascular Pharmacology and Therapeutics, 1996
- Use of Niacin as a DrugAnnual Review of Nutrition, 1991
- Effects of colestipol-niacin therapy on human femoral atherosclerosis.Circulation, 1991
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975
- Nicotinic Acid in the Treatment of HypercholesterolemiaAngiology, 1972
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955